CellBion
Seoul · Founded 2010
About CellBion
CellBion specializes in radiopharmaceuticals and radioligand therapy. The company's services include diagnostic drug and medication research and development for cardiovascular diseases, inflammation, prostate cancer, imaging agents for bones, and kidney scintigraphy.
Company Facts
- Founded: 2010
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $5.9M
- Funding stage: IPO
- Last round: Series Unknown (Oct 2023)
- Ticker: kosdaq:308430
- Website: http://www.cellbion.co.kr
- Phone: 02-743-3311
Industries & Categories
Biotechnology, Pharmaceutical, Therapeutics
Canonical: https://fsome.com/organization/cellbion-35580 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.